Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

被引:0
作者
Li-juan Tang
Guo-kang Sun
Ting-juan Zhang
De-hong Wu
Jing-dong Zhou
Bei-bei Ma
Zi-jun Xu
Xiang-mei Wen
Qin Chen
Dong-ming Yao
Jun Qian
Ji-chun Ma
Jiang Lin
机构
[1] Affiliated People’s Hospital of Jiangsu University,Laboratory Center
[2] Affiliated People’s Hospital of Jiangsu University,Department of Hematology
[3] The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City,Department of Hematology
[4] The Third People’s Hospital of Kunshan City,undefined
来源
Cancer Cell International | / 19卷
关键词
MiR-29c expression; Acute myeloid leukemia; Prognostic; Decitabine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 490 条
[1]  
Bowman RL(2018)Clonal Hematopoiesis and evolution to hematopoietic malignancies Cell Stem Cell 22 157-170
[2]  
Busque L(2018)A prospective analysis of human leukemogenesis Stem Cell Rep 11 1034-1039
[3]  
Levine RL(2017)Acute lymphoblastic leukemia: a genomic perspective Bol Med Hosp Infant Mex 74 13-26
[4]  
Eaves CJ(2013)Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia N Engl J Med 368 2059-2074
[5]  
Jimenez-Morales S(2010)DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer Cell 17 13-27
[6]  
Hidalgo-Miranda A(2018)A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target Leukemia 32 865-873
[7]  
Ramirez-Bello j(2016)The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation Leukemia 30 789-799
[8]  
Ley TJ(2018)Epigenetic deregulation in chronic lymphocytic leukemia: clinical and biological impact Semin Cancer Biol 51 1-11
[9]  
Miller C(2017)MicroRNA therapeutics: towards a new era for the management of cancer and other diseases Nat Rev Drug Discov 16 203-222
[10]  
Ding L(2017)MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts Blood 130 1290-1301